tert-Butyl 2-(trifluoromethyl)spiro[indoline-3,4'-piperidine]-1'-carboxylate

Catalog No. :
ACWUWZ096
CAS No. :
1251004-24-6
Molecular Formula :
C18H23F3N2O2
Molecular Weight :
356.39

IUPAC Name:tert-Butyl 2-(trifluoromethyl)spiro[indoline-3,4'-piperidine]-1'-carboxylate

tert-Butyl 2-(trifluoromethyl)spiro[indoline-3,4'-piperidine]-1'-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$866.00Login to see priceInquiryInquiry
250mg95%$1539.00Login to see priceInquiryInquiry
1g95%$3368.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(trifluoromethyl)spiro[indoline-3,4'-piperidine]-1'-carboxylate
IUPAC Nametert-Butyl 2-(trifluoromethyl)spiro[indoline-3,4'-piperidine]-1'-carboxylate
Molecular FormulaC18H23F3N2O2
Molecular Weight356.39
SMILESO=C(N1CCC2(CC1)C(C(F)(F)F)NC3=C2C=CC=C3)OC(C)(C)C
InChI KeyOTASCASONTYJDI-UHFFFAOYSA-N
Synonym2-Methyl-2-{[2-(Trifluoromethyl)Spiro[Indole-3,4'-Piperidine]-1'-Yl]Carbonyloxy}Propylidyne;2-Methyl-2-{[2-(Trifluoromethyl)Spiro[Indole-3,4-Piperidine]-1-Yl]Carbonyloxy}Propylidyne(WX105189);Spiro[3H-indole-3,4'-piperidine]-1'-carboxylic acid, 1,2-dihydro-2-(trifluoromethyl)-, 1,1-dimethylethyl ester;tert-butyl 2-(trifluoromethyl)spiro[indoline-3,4-piperidine]-1-carboxylate
CAS No.1251004-24-6

Synthetic Route by SureRoute

1. ACWUWZ096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWUWZ096 route product structure diagram
    ACWUWZ0961251004-24-6
Inquiry

2. ACWUWZ096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWUWZ096 route product structure diagram
    ACWUWZ0961251004-24-6
Inquiry

Comments (0)